159 related articles for article (PubMed ID: 6315273)
1. The clinical application of converting enzyme inhibitors.
Brunner HR; Turini GA; Waeber B; Nussberger J; Biollaz J
Clin Exp Hypertens A; 1983; 5(7-8):1355-66. PubMed ID: 6315273
[TBL] [Abstract][Full Text] [Related]
2. [What have we learned about inhibitors of the renin-angiotensin system?].
Waeber B; Nussberger J; Brunner HR
Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
Kubo SH; Cody RJ
Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
[TBL] [Abstract][Full Text] [Related]
4. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
Laragh JH
Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Cody RJ
Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
7. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
8. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
9. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
Robertson JI
J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1986 Oct; 81(4C):36-9. PubMed ID: 3022583
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitors and moderate hypertension.
McAreavey D; Robertson JI
Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
[TBL] [Abstract][Full Text] [Related]
13. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Cody RJ; Laragh JH; Atlas SA; Case DB
J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
[TBL] [Abstract][Full Text] [Related]
15. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
[TBL] [Abstract][Full Text] [Related]
16. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Oda M; Ino Y; Suzuki K; Sato T; Iwamoto S; Iwaki M
Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
[TBL] [Abstract][Full Text] [Related]
20. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
